Prosight Management, LP
Filing Date
Global Rank
#2,349
/ 8,604
▲ 360
· as of Mar 2026
Top Industry
Biotechnology
60.4%
3Y Alpha vs SPY
-16.4%
Period ended 3 months ago
Filed May 15, 2026 · 54d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+17.7%
SPY
+76.5%
Annualised alpha
-15.3%
Max drawdown
−45.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
46 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
8.7%
−0.3 pts
Top 5
40.6%
+5.9 pts
Top 10
65.0%
+7.8 pts
HHI
518
Diversified+68
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.8% | $608,845,822 |
| Industrials | 0.2% | $974,008 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
19 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | +2,622,937 | 5,004,439 | $32,178,542 | |
| OKUR | OnKure Therapeutics, Inc. | +1,337,472 | 2,154,381 | $8,919,137 | |
| JANX | Janux Therapeutics, Inc. | +1,157,477 | 3,550,000 | $49,345,000 | |
| KURA | Kura Oncology, Inc. | +827,100 | 3,356,700 | $27,289,971 | |
| BSX | Boston Scientific Corp | +585,547 | 795,547 | $49,920,574 | |
| PRCT | PROCEPT BioRobotics Corp | +565,000 | 1,945,000 | $48,644,450 | |
| LKFT | Lakefront Biotherapeutics NV | +475,888 | 1,550,000 | $46,500,000 | |
| WGS | GeneDx Holdings Corp. | +468,463 | 523,463 | $33,616,793 | |
| NKTR | Nektar Therapeutics | +180,367 | 735,000 | $52,883,250 | |
| KIDS | Orthopediatrics Corp | +165,658 | 302,399 | $4,799,072 | |
| PHR | Phreesia, Inc. | +122,848 | 1,100,000 | $9,218,000 | |
| PLRX | Pliant Therapeutics, Inc. | +111,856 | 1,667,600 | $2,101,176 | |
| TERN | Terns Pharmaceuticals, Inc. | +107,300 | 202,300 | $10,665,256 | |
| SNDX | Syndax Pharmaceuticals Inc | +105,000 | 770,000 | $17,987,200 | |
| ABVX | Abivax S.A. | +88,000 | 105,000 | $11,691,750 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +87,096 | 350,000 | $12,712,000 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | +58,891 | 76,000 | $25,146,120 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | +13,236 | 697,108 | $6,545,844 | |
| ZYME | Zymeworks Inc. | +8,656 | 539,049 | $13,497,786 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
10 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MGTX | MeiraGTx Holdings plc | −579,817 | 2,629,971 | $22,775,548 | |
| ROIV | Roivant Sciences Ltd. | −447,162 | 180,000 | $4,986,000 | |
| CON | Concentra Group Holdings Parent, Inc. | −385,208 | 505,822 | $10,849,881 | |
| TBI | TrueBlue, Inc. | −193,447 | 249,107 | $974,008 | |
| ADCT | ADC Therapeutics SA | −177,338 | 8,300,000 | $31,125,000 | |
| TECX | Tectonic Therapeutic, Inc. | −155,128 | 79,872 | $2,468,843 | |
| IMVT | Immunovant, Inc. | −67,579 | 175,825 | $4,367,493 | |
| RCKT | Rocket Pharmaceuticals, Inc. | −60,086 | 683,856 | $2,448,204 | |
| RNTX | Rein Therapeutics, Inc. | −31,000 | 411,600 | $535,080 | |
| VEEV | Veeva Systems Inc | −3,653 | 86,480 | $15,191,076 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
16 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALKS | Alkermes plc. | 513,632 | $18,162,027 | |
| SDGR | Schrodinger, Inc. | 510,578 | $5,800,166 | |
| EBS | Emergent BioSolutions Inc. | 639,118 | $5,304,679 | |
| ICUI | Icu Medical Inc/De | 27,450 | $3,545,167 | |
| UPB | Upstream Bio, Inc. | 241,123 | $2,170,107 | |
| OMER | Omeros Corp | 174,800 | $1,845,888 | |
| ISRG | Intuitive Surgical Inc | 4,000 | $1,843,960 | |
| ANTX | AN2 Therapeutics, Inc. | 515,754 | $1,763,878 | |
| RGNX | REGENXBIO Inc. | 200,000 | $1,676,000 | |
| COYA | Coya Therapeutics, Inc. | 420,360 | $1,656,218 | |
| VKTX | Viking Therapeutics, Inc. | 45,000 | $1,464,300 | |
| IRTC | iRhythm Holdings, Inc. | 10,000 | $1,180,200 | |
| IMRX | Immuneering Corp | 123,409 | $650,365 | |
| PVLA | Palvella Therapeutics, Inc. | 5,000 | $623,250 | |
| NVCR | NovoCure Ltd | 50,400 | $549,360 | |
| TMDX | TransMedics Group, Inc. | 5,000 | $497,050 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
8 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ICLR | Icon PLC | 110,000 | $20,044,200 | |
| FOLD | AMICUS THERAPEUTICS, INC. | 1,150,000 | $16,376,000 | |
| SEM | Select Medical Holdings Corp | 1,035,086 | $15,371,027 | |
| AVTR | Avantor, Inc. | 898,499 | $10,296,798 | |
| LH | Labcorp Holdings Inc. | 34,532 | $8,663,388 | |
| CDNA | CareDx, Inc. | 250,000 | $4,710,000 | |
| BBIO | BridgeBio Pharma, Inc. | 30,000 | $2,294,700 | |
| TEM | Tempus AI, Inc. | 35,000 | $2,066,750 | |
| No positions match the current search. | ||||
46 positions ·
$609,819,830 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 735,000 | $52,883,250 | 8.67% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 795,547 | $49,920,574 | 8.19% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
Added | 3,550,000 | $49,345,000 | 8.09% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Added | 1,945,000 | $48,644,450 | 7.98% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
Added | 1,550,000 | $46,500,000 | 7.63% | |
| WGS |
GeneDx Holdings Corp.
Healthcare
|
Added | 523,463 | $33,616,793 | 5.51% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Added | 5,004,439 | $32,178,542 | 5.28% | |
| ADCT |
ADC Therapeutics SA
Healthcare
|
Reduced | 8,300,000 | $31,125,000 | 5.10% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 3,356,700 | $27,289,971 | 4.48% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 76,000 | $25,146,120 | 4.12% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Reduced | 2,629,971 | $22,775,548 | 3.73% | |
| ALKS |
Alkermes plc.
Healthcare
|
NEW | 513,632 | $18,162,027 | 2.98% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 770,000 | $17,987,200 | 2.95% | |
| VEEV |
Veeva Systems Inc
Healthcare
|
Reduced | 86,480 | $15,191,076 | 2.49% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
Added | 539,049 | $13,497,786 | 2.21% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
Added | 350,000 | $12,712,000 | 2.08% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 105,000 | $11,691,750 | 1.92% | |
| CON |
Concentra Group Holdings Parent, Inc.
Healthcare
|
Reduced | 505,822 | $10,849,881 | 1.78% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 202,300 | $10,665,256 | 1.75% | |
| PHR |
Phreesia, Inc.
Healthcare
|
Added | 1,100,000 | $9,218,000 | 1.51% | |
| OKUR |
OnKure Therapeutics, Inc.
Healthcare
|
Added | 2,154,381 | $8,919,137 | 1.46% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
Added | 697,108 | $6,545,844 | 1.07% | |
| SDGR |
Schrodinger, Inc.
Healthcare
|
NEW | 510,578 | $5,800,166 | 0.95% | |
| EBS |
Emergent BioSolutions Inc.
Healthcare
|
NEW | 639,118 | $5,304,679 | 0.87% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 180,000 | $4,986,000 | 0.82% | |
| KIDS |
Orthopediatrics Corp
Healthcare
|
Added | 302,399 | $4,799,072 | 0.79% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Reduced | 175,825 | $4,367,493 | 0.72% | |
| ICUI |
Icu Medical Inc/De
Healthcare
|
NEW | 27,450 | $3,545,167 | 0.58% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 79,872 | $2,468,843 | 0.40% | |
| RCKT |
Rocket Pharmaceuticals, Inc.
Healthcare
|
Reduced | 683,856 | $2,448,204 | 0.40% | |
| UPB |
Upstream Bio, Inc.
Healthcare
|
NEW | 241,123 | $2,170,107 | 0.36% | |
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Added | 1,667,600 | $2,101,176 | 0.34% | |
| OMER |
Omeros Corp
Healthcare
|
NEW | 174,800 | $1,845,888 | 0.30% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
NEW | 4,000 | $1,843,960 | 0.30% | |
| ANTX |
AN2 Therapeutics, Inc.
Healthcare
|
NEW | 515,754 | $1,763,878 | 0.29% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 250,244 | $1,704,161 | 0.28% | |
| RGNX |
REGENXBIO Inc.
Healthcare
|
NEW | 200,000 | $1,676,000 | 0.27% | |
| COYA |
Coya Therapeutics, Inc.
Healthcare
|
NEW | 420,360 | $1,656,218 | 0.27% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
NEW | 45,000 | $1,464,300 | 0.24% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
NEW | 10,000 | $1,180,200 | 0.19% | |
| TBI |
TrueBlue, Inc.
Industrials
|
Reduced | 249,107 | $974,008 | 0.16% | |
| IMRX |
Immuneering Corp
Healthcare
|
NEW | 123,409 | $650,365 | 0.11% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
NEW | 5,000 | $623,250 | 0.10% | |
| NVCR |
NovoCure Ltd
Healthcare
|
NEW | 50,400 | $549,360 | 0.09% | |
| RNTX |
Rein Therapeutics, Inc.
Healthcare
|
Reduced | 411,600 | $535,080 | 0.09% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
NEW | 5,000 | $497,050 | 0.08% |